Latex allergy
DOI: 10.32364/2587-6821-2025-9-2-7
E.B. Belan, A.A. Zheltova
Volgograd State Medical University, Volgograd, Russian Federation
The objective of this review is to provide a comprehensive summary of current knowledge regarding latex allergy (LA). Hevea brasiliensis latex is extensively utilized in the manufacture of rubber products; however, its constituent components possess significant allergenic potential. The prevalence of LA ranges from 1.0% to 7.6%, and it is more commonly observed in individuals with an atopic phenotype. The risk of sensitization and the spectrum of clinical manifestations are determined by the specific sensitizing component of the allergen molecule. To date, 15 allergenic components (Hev b 1–15) have been identified. Patients with spina bifida and urogenital malformations (primarily sensitized to Hev b 1 and Hev b 3), as well as healthcare workers (predominantly sensitized to Hev b 5 and Hev b 6.01/6.02), are at highest risk for developing LA. Furthermore, latex allergens demonstrate widespread cross-reactivity with certain fruits and vegetables, predominantly of South American origin. Foods with high latex protein content include avocado, kiwi, banana, and chestnut; moderate amounts are found in apple, carrot, celery, papaya, potato, tomato, and melon. The diagnosis of LA is based upon clinical history, physical examination, and the detection of allergen-specific IgE. Thus, patients with spina bifida and urogenital abnormalities, as well as medical staff, are at the greatest risk of developing AL. Patient management is centered on the implementation of avoidance strategies and consideration of potential cross-reactive foods.
Keywords: allergy, latex, Hevea brasiliensis, Hev b.
For citation: Belan E.B., Zheltova A.A. Latex allergy. Russian Medical Inquiry. 2025;9(2):138–142 (in Russ.). DOI: 10.32364/2587-6821-2025-9-2-7
About the authors:
Eleonora B. Belan — Dr. Sc. (Med.), Professor, Head of the Department of Immunology and Allergology, Volgograd State Medical University; 1, Pavshikh Boitsov Square, Volgograd, 400131, Russian Federation; ORCID iD 0000-0003-2674-4289
Anastasia A. Zheltova — C. Sc. (Med.), Associate Professor of the Department of Immunology and Allergology, Volgograd State Medical University; 1, Pavshikh Boitsov Square, Volgograd, 400131, Russian Federation; ORCID iD 0000-0002-8078-6407
Contact information: Eleonora B. Belan, e-mail: belan.eleonora@yandex.ru
Financial Disclosure: no authors have a financial or property interest in any material or method mentioned.
There is no conflict of interest.
Received 13.01.2025.
Revised 05.02.2025.
Accepted 28.02.2025.
2. Stern G. Überempfindlichkeit Gegen Kautschuk als Ursache von Urticaria und Quinckeschem Ödem. Klin Wochenschr. 1927;6:1096–1097. DOI: 10.1007/BF01890315
3. Grimm A. Überempfindlichkeit Gegen Kautschuk Als Ursache von Urticaria und Quinckeschem Ödem. Klin Wochenschr. 1927;6:1479. DOI: 10.1007/BF01718534
4. Wu М., McIntosh J., Liu J. Current prevalence rate of latex allergy: why it remains a problem? J Occup Health. 2016;58:138–144. DOI: 10.1539/joh.15-0275-RA
5. Parisi C.A.S., Kelly K.J., Ansotegui I.J. et al. Update on latex allergy: New insights into an old problem. World Allergy Organ J. 2021;14(8):100569. DOI: 10.1016/j.waojou.2021.100569
6. Yadav K., Gupta N. Latex allergy in healthcare workers: A review. Karnataka Paediatric J. 2023;38(4):110–116. DOI: 10.25259/KPJ_44_2023
7. Agarwal N., McDonnell S., Khan W. Management of latex hyper-sensitivity in the perioperative setting. J Perioper Pract. 2020;30(7–8):199–203. DOI: 10.1177/1750458919882222
8. Reinheimer G., Ownby D.R. Prevalence of latex-specific IgE antibodies in patients being evaluated for allergy. Ann Allergy Asthma Immunol. 1995;74:184–187. DOI: 10.1186/1742-4933-11-7
9. Bedolla-Barajas M., Machuca-Rincón M.L., Morales-Romero J. et al. Self-reported prevalence of latex allergy and associated factors in healthcare workers. Rev Alerg Mex. 2017;64(4):430–438. DOI: 10.29262/ram.v64i4.289
10. Andrade K.L., Ramlow H., Floriano J.F. et al. Latex and natural rubber: recent advances for biomedical applications. Polímeros: Ciência e Tecnologia. 2022;32(2):e2022015. DOI: 10.1590/0104-1428.20210114
11. Гулько С.В., Бабаджанова Г.Ю. Аллергия на латекс. Медицина экстремальных ситуаций. 2023;4:25. DOI: 10.47183/mes.2023.064Gulko S.V., Babadjanova G.Yu. Latex allergy. Extreme Medicine. 2023;25(4):26–38. DOI: 10.47183/mes.2021.064
12. Kose S., Mandiracioglu A., Tatar B. et al. Prevalence of latex allergy among healthcare workers in Izmir (Turkey). Cent Eur J Public Health. 2014;22:262–265. DOI: 10.21101/cejph.a3912
13. Akasawa A., Hsieh L.S., Martin B.M. et al. A novel acidic allergen, Hev b 5, in latex. Purification, cloning and characterization. J Biol Chem. 1996;271(41):25389–25393. DOI: 10.1074/jbc.271.41.25389
14. Gaspar A., Raulf-Heimsoth M., Rihs H.P. et al. Hev b 5: Latex Allergen Implicated in Clinically Relevant Cross-Reactivity With Manioc. J Investig Allergol Clin Immunol. 2012;22(6):437–459. PMID: 23101196
15. Santos K.S., Gadermaier G., Vejvar E. et al. Novel allergens from ancient foods: Man e 5 from manioc (Manihot esculenta Crantz) cross reacts with Hev b 5 from latex. Mol Nutr Food Res. 2013;57:1100–1109. DOI: 10.1002/mnfr.201200433
16. Villata D., Asero R. Sensitization to the pollen pan-allergen profilin. Is the detection of immunoglobulin E to multiple homologous proteins from different sources clinically useful? J Investig Allergol Clin Immunol. 2010;20(7):591–595. PMID: 21314000
17. Liccardi G., D'Amato G., Canonica W. et al. Systemic reactions from skin testing: literature review. J Investig Allergol Clin Immunol. 2006;16(2):75–78. PMID: 16689179
18. Bernardini R., Pucci N., Azzari C. et al. Sensitivity and specificity of different skin prick tests with latex extracts in pediatric patients with suspected natural rubber latex allergy — a cohort study. Pediatr Allergy Immunol. 2008;19:315–318. DOI: 10.1111/j.1399-3038.2007.00662.x
19. Kelly K.J., Pearson M.L., Kurup V.P. et al. A cluster of anaphylactic reactions in children withspina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol. 1994;94:53–61. DOI: 10.1016/0091-6749(94)90071-x
20. Gurlek F. A Current Overview of Latex Allergy. Asthma Allergy Immunol. 2024;22:1–9. DOI: 10.21911/aai.236
21. Aruanno A., Chini R., Nucera E. Efficacy of omalizumab in reducing latex allergy. Adv Dermatol Allergol. 2021;38(5):921–923. DOI: 10.5114/ada.2021.110072
This work is licensed under a Creative Commons «Attribution» 4.0 License.
